학술논문

Optimizing Outcomes with Myeloablative Conditioning in Older Patients: Efficacy and Safety of Precision Engineered Orca-T in Patients > 55 Years Old with Hematologic Malignancies
Document Type
Abstract
Source
In Transplantation and Cellular Therapy February 2024 30(2) Supplement:S57-S57
Subject
Language
ISSN
2666-6367